Cancer Detection With the help of Liquid Biopsy

Cancer Detection With the help of Liquid Biopsy – An Insight!

With the rising incidence of chronic and lifestyle diseases in people, the demand for diagnostic tests is also increasing in the healthcare industry. With more and more people dying with cancer every day and more people getting affected, diagnostics services for cancer must be improved. Biopsy is the most common test conducted to check the presence of cancer biomarkers in a body. Based on the type of cancer a patient is suffering from, the doctor performs the biopsy which is suitable for the cancer type.

Normally, a tissue biopsy is considered wherein a sample of the tissue is extracted from the body to test the presence of cancerous biomarkers. However, this is a minimally invasive procedure, a small incision is made to extract the affected tissue from the body. Organizations as on date are conducting extensive research to develop new ways to detect cancer and subsequently identify the ways it can be treated. One such way to diagnose cancer is through liquid biopsy. It is a non-invasive procedure, which can detect the presence of cancer biomarkers in the fluids of the body, such as blood. This test can possibly help in diagnosing the cancer at an early stage and planning the right treatment for it. The non-invasive nature of the test is likely to increase the demand for it, thus, leading to an increase in the overall liquid biopsy market.

A recent market intelligence report was published by BIS Research on liquid biopsy market and what is the growth projected of the market. The report also talks about the trends in the market related to applications, types and the competitive scenario. It also indicates the regions where the liquid biopsy procedure has already been tested and the response it has received.

Important Links:

Request the Sample: https://bisresearch.com/requestsample?id=562&type=download

https://goo.gl/HzEGVN

https://goo.gl/1HNf1v

https://goo.gl/1h6VwW

https://goo.gl/rLkVwv

Comments

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @ https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023. The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...

BIS Research ( Business Intelligence and Strategy Research)

Search This Blog